APA (7th ed.) Citation

Yadalam, P. K., Anegundi, R. V., Ramadoss, R., Shrivastava, D., Almufarrij, R. A. S., & Srivastava, K. C. (2024). AI-based 3D-QSAR model of FDA-approved repurposed drugs for inhibiting sclerostin. Technology & Health Care, 32(5), 3007. https://doi.org/10.3233/THC-231358

Chicago Style (17th ed.) Citation

Yadalam, Pradeep Kumar, Raghavendra Vamsi Anegundi, Ramya Ramadoss, Deepti Shrivastava, Raha Ahmed Shamikh Almufarrij, and Kumar Chandan Srivastava. "AI-based 3D-QSAR Model of FDA-approved Repurposed Drugs for Inhibiting Sclerostin." Technology & Health Care 32, no. 5 (2024): 3007. https://doi.org/10.3233/THC-231358.

MLA (9th ed.) Citation

Yadalam, Pradeep Kumar, et al. "AI-based 3D-QSAR Model of FDA-approved Repurposed Drugs for Inhibiting Sclerostin." Technology & Health Care, vol. 32, no. 5, 2024, p. 3007, https://doi.org/10.3233/THC-231358.